NCT04208451

Brief Summary

In this study are included patients on hemodialysis with anemia (levels of Hemoglobin\<110). After baseline measurements tha patients take Standardized Aronia melanocarpa extract for one mont and then all measurements were repeated.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2019

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 18, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 23, 2019

Completed
Last Updated

December 24, 2019

Status Verified

December 1, 2019

Enrollment Period

2 months

First QC Date

December 18, 2019

Last Update Submit

December 21, 2019

Conditions

Keywords

hemodialysisanemiaoxidative stressinflammation

Outcome Measures

Primary Outcomes (4)

  • Anemia control

    The iron levels Unit µmol/l

    two months

  • Anemia control

    The hemoglobin levels Unit g/l

    two months

  • Anemia control

    The ferritin levels Unit ng/ml

    two months

  • Anemia control

    The transferrin levels Unit g/l

    two months

Secondary Outcomes (3)

  • Oxidative stress

    two months

  • Oxidative stress

    two months

  • Oxidative stress

    two months

Other Outcomes (3)

  • Inflammation

    two months

  • Inflammation

    two months

  • Inflammation

    two months

Study Arms (1)

Experimental group

EXPERIMENTAL

Patients on hemodialysis who consumed one month Standardized Aronia Melanocrpa extract

Dietary Supplement: Alixir 400 Protect

Interventions

Alixir 400 ProtectDIETARY_SUPPLEMENT

During 30 days all patients take every day 30ml of Alixir 400 protect

Experimental group

Eligibility Criteria

Age37 Years - 68 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • regular dialysis treatment for more than 3 months, 3 times a week
  • hemoglobin values lower than 110g / L

You may not qualify if:

  • hemoglobin values lower than 80g/L,
  • the use of antioxidant and immunosuppressive therapy,
  • uncontrolled malignancies,
  • proven active bleeding
  • presence of systemic inflammation or active infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medical Science

Kragujevac, 34000, Serbia

Location

Related Publications (1)

  • Milosavljevic I, Jakovljevic V, Petrovic D, Draginic N, Jeremic J, Mitrovic M, Zivkovic V, Srejovic I, Stojic V, Bolevich S, Andjelkovic N. Standardized Aronia melanocarpa extract regulates redox status in patients receiving hemodialysis with anemia. Mol Cell Biochem. 2021 Nov;476(11):4167-4175. doi: 10.1007/s11010-021-04225-y. Epub 2021 Jul 29.

MeSH Terms

Conditions

Kidney DiseasesAnemiaInflammation

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesHematologic DiseasesHemic and Lymphatic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Isidora Milosavljevic

    Department of pharmacy, University of Kragujevac

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

December 18, 2019

First Posted

December 23, 2019

Study Start

August 1, 2019

Primary Completion

October 1, 2019

Study Completion

October 1, 2019

Last Updated

December 24, 2019

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Locations